|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
$115,928
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S5
|
$10,405,362
|
|
PISTERS, PETER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
$191,186
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
$78,102
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Regional Oncology Research Center
|
2P30CA006973-54
|
$7,060,038
|
$70,600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$67,654
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
$61,660
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
Cancer Center Support Grant
|
5P30CA068485-22
|
$5,853,094
|
$175,593
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-43
|
$5,815,389
|
$174,462
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Cancer Center Support Grant
|
5P30CA091842-16
|
$4,305,712
|
$43,057
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
5P30CA016056-40
|
$4,052,483
|
$40,525
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Core Support for Cancer Center
|
3P30CA013330-45S1
|
$3,646,138
|
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Childhood Cancer Survivor Study
|
2U24CA055727-23
|
$3,616,741
|
$1,808,371
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
5P30CA077598-19
|
$3,561,178
|
$71,224
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA
|
|
AIDS and Cancer Specimen Resource (ACSR)
|
3UM1CA181255-05S1
|
$3,000,000
|
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Genomics of Acute Myelogenous Leukemia
|
5P01CA101937-14
|
$2,917,422
|
$320,916
|
LEY, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$48,934
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
DF/HCC SPORE in Prostate Cancer
|
5P50CA090381-15
|
$2,300,000
|
$943,000
|
LODA, MASSIMO
|
DANA-FARBER CANCER INST
|
|
Mayo Clinic SPORE in Pancreatic Cancer
|
5P50CA102701-14
|
$2,300,000
|
$2,300,000
|
PETERSEN, GLORIA
|
MAYO CLINIC ROCHESTER
|
|
RPCI-UPCI Ovarian Cancer SPORE
|
5P50CA159981-05
|
$2,300,000
|
$253,000
|
ODUNSI, KUNLE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
SPORE: Brain Tumore SPORE Grant
|
5P50CA097257-15
|
$2,300,000
|
$460,000
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA042014-28
|
$2,284,983
|
$91,399
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
5P30CA051008-24
|
$2,258,441
|
$45,169
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
University of New Mexico Cancer Center Support Grant
|
5P30CA118100-13
|
$2,246,011
|
$179,681
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Cancer Therapy & Research Center at UTHSCSA
|
5P30CA054174-23
|
$2,093,000
|
$41,860
|
MESA, RUBEN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
NK cells, their receptors, transplantation and cancer therapy
|
5P01CA111412-12
|
$1,842,904
|
$552,871
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
|
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study
|
5U01CA206110-03
|
$1,745,632
|
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Barrett's Esophagus: Predictors of Progression
|
5P01CA091955-14
|
$1,731,544
|
$865,772
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Genetics of Prostate Cancer in Africa
|
5U01CA184374-03
|
$1,707,746
|
$1,707,746
|
REBBECK, TIMOTHY
|
DANA-FARBER CANCER INST
|
|
Genomics of Acute Myelogenous Leukemia
|
3P01CA101937-14S1
|
$1,458,713
|
$160,458
|
LEY, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
5U54CA163069-07
|
$1,414,315
|
$28,286
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
Great Lakes New England Clinical Validation Center
|
5U01CA086400-17
|
$1,315,798
|
$263,160
|
BRENNER, DEAN
|
UNIVERSITY OF MICHIGAN
|
|
Georgia NCI Community Oncology Research Program (NCORP)
|
5UG1CA189997-04
|
$1,304,055
|
$652,028
|
CANTUARIA, GUILHERME
|
NORTHSIDE HOSPITAL ATLANTA
|
|
Risk and penetrance of mutations from breast cancer testing panels.
|
5R01CA192393-04
|
$1,263,145
|
$1,263,145
|
COUCH, FERGUS
|
MAYO CLINIC ROCHESTER
|
|
MMC, VICC, & TSU: PARTNERS IN ELIMINATING CANCER DISPARITIES (2 of 3)
|
5U54CA163072-08
|
$1,233,813
|
$49,353
|
MOSES, HAROLD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Genetic Modifiers of Initiation and Progression of Mammary Cancer
|
ZIA BC 011255
|
$1,232,548
|
$123,255
|
Hunter, Kent
|
CCR (NCI)
|
|
Controlling Esophageal Cancer: A Collaborative Modeling Approach
|
7U01CA199336-04
|
$1,173,755
|
|
HUR, CHIN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
|
4R44CA217587-02
|
$1,165,750
|
|
PEREZ, KRISTY
|
CIVATECH ONCOLOGY, INC.
|
|
UCLA SPORE in Prostate Cancer
|
3P50CA092131-15S1
|
$1,162,609
|
|
REITER, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
SPORE in Genitourinary Cancer
|
3P50CA091846-15S1
|
$1,162,609
|
|
DINNEY, COLIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE in Breast Cancer
|
3P50CA098131-16S1
|
$1,162,609
|
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Development of PEGylated MTI-101 for the treatment of relapsed Myeloma
|
4R44CA221554-02
|
$1,161,570
|
|
WATERHOUSE, RIKKI
|
MODULATION THERAPEUTICS, INC.
|
|
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
|
4R44CA217591-02
|
$1,125,311
|
|
KAHN, STUART
|
SYNTRIX BIOSYSTEMS, INC.
|
|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
4R44CA224460-02
|
$1,111,364
|
|
DAUNCH, WILLIAM
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
Targeting Nrf2 for Cancer Chemoprevention
|
7R35CA197222-04
|
$1,060,913
|
|
KENSLER, THOMAS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,059,524
|
$529,762
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SQSTM1/p62-targeted Small Molecules for Multiple Myeloma Disease
|
4R44CA210882-02
|
$1,000,000
|
|
LEE, JAMES
|
ID4PHARMA, LLC
|
|
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
|
3U01DK108328-04S2
|
$1,000,000
|
|
YUAN, YING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Novel IL-15 Superagonist Therapy for Bladder Cancer
|
6R44CA156740-05
|
$999,919
|
|
RHODE, PETER
|
ALTOR BIOSCIENCE. LLC
|
Total relevant funding to Genetic Testing for this search: $26,198,238
|